Galbraith Revenue and Competitors
Estimated Revenue & Valuation
- Galbraith's estimated annual revenue is currently $42.4M per year.
- Galbraith's estimated revenue per employee is $165,000
Employee Data
- Galbraith has 257 Employees.
- Galbraith grew their employee count by 2% last year.
Galbraith's People
Name | Title | Email/Phone |
---|
Galbraith Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $47.2M | 286 | 12% | N/A | N/A |
#2 | $4.1M | 34 | -26% | N/A | N/A |
#3 | $0.7M | 9 | N/A | N/A | N/A |
#4 | $66.2M | 353 | 5% | N/A | N/A |
#5 | $8.8M | 65 | 0% | N/A | N/A |
#6 | $46.7M | 283 | 8% | N/A | N/A |
#7 | $14.3M | 95 | -4% | N/A | N/A |
#8 | $85.3M | 455 | 39% | N/A | N/A |
#9 | $5M | 44 | 19% | $221.1M | N/A |
#10 | $38M | 230 | 31% | N/A | N/A |
What Is Galbraith?
A leading independent property consultancy. Estate Agency Sales & Lettings | Rural | Commercial Energy | Forestry | Building Surveying Letting Agent Registration Number: LARN1810017
keywords:N/AN/A
Total Funding
257
Number of Employees
$42.4M
Revenue (est)
2%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Galbraith News
2022-04-20 - Investment firm offers to buy Vancouver, B.C.-based biotech Zymeworks for
$733M in cash
Zymeworks CEO Kenneth Galbraith. (Zymeworks Photo). Global investment firm All Blue Capital has offered to buy Zymeworks, a public biotech...
2022-04-13 - Former Steelhead, fan favorite, Lance Galbraith dies at 42
Lance Galbraith, a two-time Kelly Cup champion with the Idaho Steelheads who was widely known for his crowd-pleasing antics during his...
2022-04-06 - Former 67's player Lance Galbraith dead at 42
Galbraith, who passed away Friday, had such a way about him he even drew the ire of wrestler Bret (Hitman) Hart at the 1998-99 Memorial Cup in...
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $62.2M | 257 | N/A | N/A |
#2 | $82M | 257 | -4% | N/A |
#3 | $76.3M | 257 | 1% | N/A |
#4 | $210.2M | 257 | -11% | N/A |
#5 | $64.5M | 257 | 34% | N/A |